TRACER CRO

TRACER designs and executes Phase 0–II imaging studies using PET, SPECT, optical and other molecular-imaging techniques. It supports tracer selection, radiochemistry and CMC, regulatory submissions, clinical operations, image and data analysis and biomarker strategy. The company's specialist model is especially relevant for radiopharmaceutical, oncology, inflammation, infectious-disease and cardiovascular programs.